New bladder cancer treatment enters human testing
NCT ID NCT07445308
Summary
This early-stage clinical trial is testing a new drug called SPGL008, both by itself and combined with an existing treatment (BCG), for people with high-risk non-muscle-invasive bladder cancer. The main goals are to find a safe dose and see if the treatment shows early signs of helping patients. The study will enroll about 120 adults who are not eligible for or do not want to have their bladder surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMIBC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.